Celon Pharma S.A. (WSE:CLN)
Poland flag Poland · Delayed Price · Currency is PLN
22.80
+0.60 (2.70%)
Oct 3, 2025, 5:00 PM CET

Celon Pharma Income Statement

Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Operating Revenue
187.89176.62164.39161.92169.56135.48
Upgrade
Other Revenue
18.3328.9350.2731.9726.5321.97
Upgrade
206.22205.55214.66193.89196.09157.45
Upgrade
Revenue Growth (YoY)
-0.78%-4.25%10.72%-1.12%24.54%53.99%
Upgrade
Cost of Revenue
72.4263.1766.8266.4661.7236.64
Upgrade
Gross Profit
133.79142.38147.85127.42134.37120.81
Upgrade
Selling, General & Admin
124.84120.04111.12107.790.1183.44
Upgrade
Other Operating Expenses
17.7721.9815.0613.5213.56.93
Upgrade
Operating Expenses
195.24195.31176.2165.32144.96124.91
Upgrade
Operating Income
-61.44-52.94-28.35-37.9-10.59-4.1
Upgrade
Interest Expense
-2.08-2.47-2.66-1.67-1.55-0.67
Upgrade
Interest & Investment Income
0.310.160.371.850.080.14
Upgrade
Earnings From Equity Investments
-20.12-5.55----
Upgrade
Currency Exchange Gain (Loss)
-0.08-0.40.03-0.4-2.59-0.64
Upgrade
Other Non Operating Income (Expenses)
3.755.79.531.11-0.57-0.75
Upgrade
EBT Excluding Unusual Items
-79.67-55.49-21.08-37.01-15.22-6.02
Upgrade
Gain (Loss) on Sale of Assets
0.680.681.110.560.130.43
Upgrade
Asset Writedown
13.1915.45----
Upgrade
Pretax Income
-65.8-39.37-19.97-36.45-15.09-5.59
Upgrade
Income Tax Expense
3.09-4.928.162.83-3.48-4.67
Upgrade
Net Income
-68.88-34.45-28.12-39.28-11.61-0.92
Upgrade
Net Income to Common
-68.88-34.45-28.12-39.28-11.61-0.92
Upgrade
Shares Outstanding (Basic)
535351514745
Upgrade
Shares Outstanding (Diluted)
535351514745
Upgrade
Shares Change (YoY)
0.08%2.86%0.04%9.32%3.74%-
Upgrade
EPS (Basic)
-1.31-0.66-0.55-0.77-0.25-0.02
Upgrade
EPS (Diluted)
-1.32-0.66-0.55-0.77-0.25-0.02
Upgrade
Free Cash Flow
-53.44-34.13-41.13-38.612.6-27.74
Upgrade
Free Cash Flow Per Share
-1.02-0.65-0.81-0.760.06-0.62
Upgrade
Dividend Per Share
--0.0800.0900.2900.070
Upgrade
Dividend Growth
---11.11%-68.97%314.29%-12.50%
Upgrade
Gross Margin
64.88%69.27%68.87%65.72%68.53%76.73%
Upgrade
Operating Margin
-29.80%-25.75%-13.21%-19.55%-5.40%-2.60%
Upgrade
Profit Margin
-33.40%-16.76%-13.10%-20.26%-5.92%-0.58%
Upgrade
Free Cash Flow Margin
-25.91%-16.61%-19.16%-19.91%1.33%-17.62%
Upgrade
EBITDA
-30.66-14.978.63-2.5727.8425.49
Upgrade
EBITDA Margin
-14.87%-7.29%4.02%-1.33%14.20%16.19%
Upgrade
D&A For EBITDA
30.7837.9636.9935.3338.4329.59
Upgrade
EBIT
-61.44-52.94-28.35-37.9-10.59-4.1
Upgrade
EBIT Margin
-29.80%-25.75%-13.21%-19.55%-5.40%-2.60%
Upgrade
Revenue as Reported
207.18207.19216.57194.59199.11159.99
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.